MDGL Operating Income Growth
Madrigal Pharmaceuticals Inc · Operating Income Growth
MDGL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-4.13%period ending
MDGL TTM Operating Income YoY % (25.87% → -4.13%)
Year-over-year change
High-resolution chart · PNG
MDGL operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -4.1322% | |
| 26.2589% | |
| 39.7243% | |
| 43.8953% | |
| 41.576% | |
| 6.3957% | |
| -30.8487% | |
| -57.2072% | |
| -60.4505% | |
| -44.5015% | |
| -29.6095% | |
| -27.7587% | |
| -29.2918% | |
| -27.2087% | |
| -21.0692% | |
| -14.9249% | |
| -9.6794% | |
| -11.4791% | |
| -17.3264% | |
| -34.0901% | |
| -63.5741% | |
| -92.9748% | |
| -117.6147% | |
| -122.8105% | |
| -113.9033% | |
| -122.0251% | |
| -133.4497% | |
| -126.1647% | |
| -105.3139% | |
| -56.4981% | |
| -26.8854% | |
| -13.9626% | |
| 10.2702% | |
| -5.9273% | |
| -1.5317% | |
| 10.0413% | |
| 4.1201% | |
| 41.9147% | |
| 53.2934% | |
| 55.5579% | |
| 52.3737% | |
| 33.9793% | |
| 19.4649% | |
| 11.8593% | |
| 11.8725% | |
| 9.7907% | |
| 4.1207% | |
| -6.9459% | |
| -20.4968% | |
| -35.3783% | |
| -43.6783% | |
| -52.9966% | |
| -45.7561% | |
| -35.9018% | |
| -34.1367% | |
| -22.7719% | |
| -23.0569% | |
| -27.0036% | |
| -23.1286% | |
| -22.6537% | |
| -144.7529% | |
| -141.2982% | |
| -146.5273% | |
| -158.7779% | |
| 210.3154% | |
| 194.7142% | |
| 184.6288% | |
| 171.7685% | |
| -15.1445% | |
| -45.8994% | |
| -41.5208% | |
| -33.89% | |
| -17.836% | |
| -13.6521% | |
| -15.2808% | |
| -4.9262% | |
| 13.8462% | |
| 28.9646% | |
| 34.2529% | |
| 25.8712% |